nodes	percent_of_prediction	percent_of_DWPC	metapath
Ammonium lactate—Venous thrombosis—Temsirolimus—kidney cancer	0.0423	0.0423	CcSEcCtD
Ammonium lactate—Localized exfoliation—Capecitabine—kidney cancer	0.029	0.029	CcSEcCtD
Ammonium lactate—Petechiae—Temsirolimus—kidney cancer	0.0277	0.0277	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Erlotinib—kidney cancer	0.0275	0.0275	CcSEcCtD
Ammonium lactate—Extravasation—Temsirolimus—kidney cancer	0.0261	0.0261	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Sunitinib—kidney cancer	0.0238	0.0238	CcSEcCtD
Ammonium lactate—Skin exfoliation—Pazopanib—kidney cancer	0.0205	0.0205	CcSEcCtD
Ammonium lactate—Extravasation—Vinblastine—kidney cancer	0.0195	0.0195	CcSEcCtD
Ammonium lactate—Eczema—Temsirolimus—kidney cancer	0.0184	0.0184	CcSEcCtD
Ammonium lactate—Venous thrombosis—Paclitaxel—kidney cancer	0.0176	0.0176	CcSEcCtD
Ammonium lactate—Skin exfoliation—Everolimus—kidney cancer	0.0162	0.0162	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Paclitaxel—kidney cancer	0.016	0.016	CcSEcCtD
Ammonium lactate—Skin exfoliation—Erlotinib—kidney cancer	0.0156	0.0156	CcSEcCtD
Ammonium lactate—Extravasation—Dactinomycin—kidney cancer	0.0154	0.0154	CcSEcCtD
Ammonium lactate—Dry skin—Temsirolimus—kidney cancer	0.0152	0.0152	CcSEcCtD
Ammonium lactate—Venous thrombosis—Capecitabine—kidney cancer	0.0145	0.0145	CcSEcCtD
Ammonium lactate—Phlebitis—Vinblastine—kidney cancer	0.0144	0.0144	CcSEcCtD
Ammonium lactate—Dry skin—Pazopanib—kidney cancer	0.0143	0.0143	CcSEcCtD
Ammonium lactate—Skin exfoliation—Sorafenib—kidney cancer	0.0141	0.0141	CcSEcCtD
Ammonium lactate—Petechiae—Gemcitabine—kidney cancer	0.0138	0.0138	CcSEcCtD
Ammonium lactate—Extravasation—Vincristine—kidney cancer	0.0137	0.0137	CcSEcCtD
Ammonium lactate—Skin exfoliation—Sunitinib—kidney cancer	0.0135	0.0135	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Capecitabine—kidney cancer	0.0131	0.0131	CcSEcCtD
Ammonium lactate—Extravasation—Gemcitabine—kidney cancer	0.013	0.013	CcSEcCtD
Ammonium lactate—Eczema—Sorafenib—kidney cancer	0.0119	0.0119	CcSEcCtD
Ammonium lactate—Eczema—Sunitinib—kidney cancer	0.0114	0.0114	CcSEcCtD
Ammonium lactate—Phlebitis—Dactinomycin—kidney cancer	0.0113	0.0113	CcSEcCtD
Ammonium lactate—Dry skin—Everolimus—kidney cancer	0.0113	0.0113	CcSEcCtD
Ammonium lactate—Extravasation—Paclitaxel—kidney cancer	0.0109	0.0109	CcSEcCtD
Ammonium lactate—Dry skin—Erlotinib—kidney cancer	0.0109	0.0109	CcSEcCtD
Ammonium lactate—Skin exfoliation—Gemcitabine—kidney cancer	0.0109	0.0109	CcSEcCtD
Ammonium lactate—Erythema—Temsirolimus—kidney cancer	0.00997	0.00997	CcSEcCtD
Ammonium lactate—Dry skin—Sorafenib—kidney cancer	0.0098	0.0098	CcSEcCtD
Ammonium lactate—Petechiae—Capecitabine—kidney cancer	0.0095	0.0095	CcSEcCtD
Ammonium lactate—Dry skin—Sunitinib—kidney cancer	0.00943	0.00943	CcSEcCtD
Ammonium lactate—Erythema—Pazopanib—kidney cancer	0.00939	0.00939	CcSEcCtD
Ammonium lactate—Venous thrombosis—Doxorubicin—kidney cancer	0.00933	0.00933	CcSEcCtD
Ammonium lactate—Skin exfoliation—Paclitaxel—kidney cancer	0.00909	0.00909	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.00847	0.00847	CcSEcCtD
Ammonium lactate—Infection—Temsirolimus—kidney cancer	0.00809	0.00809	CcSEcCtD
Ammonium lactate—Phlebitis—Paclitaxel—kidney cancer	0.00802	0.00802	CcSEcCtD
Ammonium lactate—Skin disorder—Temsirolimus—kidney cancer	0.00791	0.00791	CcSEcCtD
Ammonium lactate—Infection—Pazopanib—kidney cancer	0.00762	0.00762	CcSEcCtD
Ammonium lactate—Skin exfoliation—Capecitabine—kidney cancer	0.00746	0.00746	CcSEcCtD
Ammonium lactate—Skin disorder—Pazopanib—kidney cancer	0.00745	0.00745	CcSEcCtD
Ammonium lactate—Erythema—Everolimus—kidney cancer	0.00742	0.00742	CcSEcCtD
Ammonium lactate—Erythema—Erlotinib—kidney cancer	0.00716	0.00716	CcSEcCtD
Ammonium lactate—Pain—Temsirolimus—kidney cancer	0.00696	0.00696	CcSEcCtD
Ammonium lactate—Phlebitis—Capecitabine—kidney cancer	0.00658	0.00658	CcSEcCtD
Ammonium lactate—Pain—Pazopanib—kidney cancer	0.00656	0.00656	CcSEcCtD
Ammonium lactate—Erythema—Sorafenib—kidney cancer	0.00644	0.00644	CcSEcCtD
Ammonium lactate—Body temperature increased—Temsirolimus—kidney cancer	0.00643	0.00643	CcSEcCtD
Ammonium lactate—Dry skin—Paclitaxel—kidney cancer	0.00634	0.00634	CcSEcCtD
Ammonium lactate—Stinging—Doxorubicin—kidney cancer	0.00622	0.00622	CcSEcCtD
Ammonium lactate—Erythema—Sunitinib—kidney cancer	0.0062	0.0062	CcSEcCtD
Ammonium lactate—Petechiae—Doxorubicin—kidney cancer	0.00612	0.00612	CcSEcCtD
Ammonium lactate—Infection—Everolimus—kidney cancer	0.00601	0.00601	CcSEcCtD
Ammonium lactate—Skin disorder—Everolimus—kidney cancer	0.00588	0.00588	CcSEcCtD
Ammonium lactate—Erythema—Dactinomycin—kidney cancer	0.00587	0.00587	CcSEcCtD
Ammonium lactate—Infection—Erlotinib—kidney cancer	0.0058	0.0058	CcSEcCtD
Ammonium lactate—Extravasation—Doxorubicin—kidney cancer	0.00577	0.00577	CcSEcCtD
Ammonium lactate—Skin disorder—Erlotinib—kidney cancer	0.00567	0.00567	CcSEcCtD
Ammonium lactate—Infection—Sorafenib—kidney cancer	0.00522	0.00522	CcSEcCtD
Ammonium lactate—Dry skin—Capecitabine—kidney cancer	0.0052	0.0052	CcSEcCtD
Ammonium lactate—Pain—Vinblastine—kidney cancer	0.0052	0.0052	CcSEcCtD
Ammonium lactate—Pain—Everolimus—kidney cancer	0.00518	0.00518	CcSEcCtD
Ammonium lactate—Rash—Temsirolimus—kidney cancer	0.00513	0.00513	CcSEcCtD
Ammonium lactate—Dermatitis—Temsirolimus—kidney cancer	0.00513	0.00513	CcSEcCtD
Ammonium lactate—Skin disorder—Sorafenib—kidney cancer	0.0051	0.0051	CcSEcCtD
Ammonium lactate—Infection—Sunitinib—kidney cancer	0.00502	0.00502	CcSEcCtD
Ammonium lactate—Pain—Erlotinib—kidney cancer	0.005	0.005	CcSEcCtD
Ammonium lactate—Erythema—Gemcitabine—kidney cancer	0.00497	0.00497	CcSEcCtD
Ammonium lactate—Skin disorder—Sunitinib—kidney cancer	0.00491	0.00491	CcSEcCtD
Ammonium lactate—Rash—Pazopanib—kidney cancer	0.00483	0.00483	CcSEcCtD
Ammonium lactate—Dermatitis—Pazopanib—kidney cancer	0.00483	0.00483	CcSEcCtD
Ammonium lactate—Skin exfoliation—Doxorubicin—kidney cancer	0.00481	0.00481	CcSEcCtD
Ammonium lactate—Body temperature increased—Everolimus—kidney cancer	0.00479	0.00479	CcSEcCtD
Ammonium lactate—Infection—Dactinomycin—kidney cancer	0.00476	0.00476	CcSEcCtD
Ammonium lactate—Body temperature increased—Erlotinib—kidney cancer	0.00462	0.00462	CcSEcCtD
Ammonium lactate—Pain—Sorafenib—kidney cancer	0.00449	0.00449	CcSEcCtD
Ammonium lactate—Pain—Sunitinib—kidney cancer	0.00432	0.00432	CcSEcCtD
Ammonium lactate—Infection—Vincristine—kidney cancer	0.00425	0.00425	CcSEcCtD
Ammonium lactate—Phlebitis—Doxorubicin—kidney cancer	0.00424	0.00424	CcSEcCtD
Ammonium lactate—Erythema—Paclitaxel—kidney cancer	0.00416	0.00416	CcSEcCtD
Ammonium lactate—Body temperature increased—Sorafenib—kidney cancer	0.00415	0.00415	CcSEcCtD
Ammonium lactate—Pain—Dactinomycin—kidney cancer	0.00409	0.00409	CcSEcCtD
Ammonium lactate—Eczema—Doxorubicin—kidney cancer	0.00407	0.00407	CcSEcCtD
Ammonium lactate—Infection—Gemcitabine—kidney cancer	0.00403	0.00403	CcSEcCtD
Ammonium lactate—Body temperature increased—Sunitinib—kidney cancer	0.004	0.004	CcSEcCtD
Ammonium lactate—Skin disorder—Gemcitabine—kidney cancer	0.00394	0.00394	CcSEcCtD
Ammonium lactate—Rash—Everolimus—kidney cancer	0.00382	0.00382	CcSEcCtD
Ammonium lactate—Dermatitis—Everolimus—kidney cancer	0.00381	0.00381	CcSEcCtD
Ammonium lactate—Body temperature increased—Dactinomycin—kidney cancer	0.00378	0.00378	CcSEcCtD
Ammonium lactate—Rash—Erlotinib—kidney cancer	0.00368	0.00368	CcSEcCtD
Ammonium lactate—Dermatitis—Erlotinib—kidney cancer	0.00368	0.00368	CcSEcCtD
Ammonium lactate—Pain—Vincristine—kidney cancer	0.00366	0.00366	CcSEcCtD
Ammonium lactate—Pain—Gemcitabine—kidney cancer	0.00347	0.00347	CcSEcCtD
Ammonium lactate—Erythema—Capecitabine—kidney cancer	0.00342	0.00342	CcSEcCtD
Ammonium lactate—Body temperature increased—Vincristine—kidney cancer	0.00338	0.00338	CcSEcCtD
Ammonium lactate—Infection—Paclitaxel—kidney cancer	0.00337	0.00337	CcSEcCtD
Ammonium lactate—Dry skin—Doxorubicin—kidney cancer	0.00335	0.00335	CcSEcCtD
Ammonium lactate—Rash—Sorafenib—kidney cancer	0.00331	0.00331	CcSEcCtD
Ammonium lactate—Dermatitis—Sorafenib—kidney cancer	0.00331	0.00331	CcSEcCtD
Ammonium lactate—Skin disorder—Paclitaxel—kidney cancer	0.0033	0.0033	CcSEcCtD
Ammonium lactate—Body temperature increased—Gemcitabine—kidney cancer	0.00321	0.00321	CcSEcCtD
Ammonium lactate—Rash—Sunitinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Ammonium lactate—Dermatitis—Sunitinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Ammonium lactate—Rash—Dactinomycin—kidney cancer	0.00302	0.00302	CcSEcCtD
Ammonium lactate—Pain—Paclitaxel—kidney cancer	0.0029	0.0029	CcSEcCtD
Ammonium lactate—Infection—Capecitabine—kidney cancer	0.00277	0.00277	CcSEcCtD
Ammonium lactate—Skin disorder—Capecitabine—kidney cancer	0.00271	0.00271	CcSEcCtD
Ammonium lactate—Rash—Vincristine—kidney cancer	0.0027	0.0027	CcSEcCtD
Ammonium lactate—Dermatitis—Vincristine—kidney cancer	0.00269	0.00269	CcSEcCtD
Ammonium lactate—Body temperature increased—Paclitaxel—kidney cancer	0.00269	0.00269	CcSEcCtD
Ammonium lactate—Rash—Gemcitabine—kidney cancer	0.00256	0.00256	CcSEcCtD
Ammonium lactate—Dermatitis—Gemcitabine—kidney cancer	0.00256	0.00256	CcSEcCtD
Ammonium lactate—Pain—Capecitabine—kidney cancer	0.00238	0.00238	CcSEcCtD
Ammonium lactate—Body temperature increased—Capecitabine—kidney cancer	0.0022	0.0022	CcSEcCtD
Ammonium lactate—Erythema—Doxorubicin—kidney cancer	0.0022	0.0022	CcSEcCtD
Ammonium lactate—Rash—Paclitaxel—kidney cancer	0.00214	0.00214	CcSEcCtD
Ammonium lactate—Dermatitis—Paclitaxel—kidney cancer	0.00214	0.00214	CcSEcCtD
Ammonium lactate—Infection—Doxorubicin—kidney cancer	0.00179	0.00179	CcSEcCtD
Ammonium lactate—Rash—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Ammonium lactate—Dermatitis—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Ammonium lactate—Skin disorder—Doxorubicin—kidney cancer	0.00175	0.00175	CcSEcCtD
Ammonium lactate—Pain—Doxorubicin—kidney cancer	0.00154	0.00154	CcSEcCtD
Ammonium lactate—Body temperature increased—Doxorubicin—kidney cancer	0.00142	0.00142	CcSEcCtD
Ammonium lactate—Rash—Doxorubicin—kidney cancer	0.00113	0.00113	CcSEcCtD
Ammonium lactate—Dermatitis—Doxorubicin—kidney cancer	0.00113	0.00113	CcSEcCtD
